- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04042948
Clinical Effect of Preventive Use of Tylenol on Fever After Removal of Drainage Tube in Lumbar Fusion Surgery
June 17, 2021 updated by: Peking University Third Hospital
Randomized Controlled Study of Fever Probability, Risk Factors and Preventive Use of Non-steroidal Anti-inflammatory Drugs on Fever After Removal of Drainage Tube After Lumbar Fusion
This study evaluates the influence of Non-steroidal Anti-inflammatory Drugs on preventing fever after the removal of drainage tube in the patients who suffered lumbar fusion surgery, if the outcome turn out positive, the preventive use of non-steroidal anti-inflammatory drugs could decrease the possibility of fever happening when we remove the tube.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
183
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Haidian
-
Beijing, Haidian, China, 110191
- Peking University Third Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult patient
- diagnosis of lumbar spinal stenosis
- perform decompression and fusion surgery and lay a drainage tube
- understand the test and could sign the name
Exclusion Criteria:
- beside the inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
preventive use non-steroidal anti-inflammatory drugs to before the removal of drainage tube
|
when we decide to remove the drainage tube, we ask the patient to take a pill of tylenol, and another pill in 12h later
|
No Intervention: Control Group
without any intervention when remove the drainage tube
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the rate of fever after the removal of drainage tube
Time Frame: 24 hours
|
we test the temperature of the patient in 24h after the removal of tube, we define fever if the temperature is higher than 37.8 degree
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the level of WBC
Time Frame: 24 hours
|
we compare the change of the level of WBC of two groups in 24h after the removal of the drainage tube
|
24 hours
|
the level of CRP
Time Frame: 24 hours
|
we compare the change of the level of CRP of two groups in 24h after the removal of the drainage tube
|
24 hours
|
the level of ESR
Time Frame: 24 hours
|
we compare the change of the level of ESR of two groups in 24h after the removal of the drainage tube
|
24 hours
|
the temperature
Time Frame: 24 hours
|
we compare the change of the level of temperature of two groups in 24h after the removal of the drainage tube
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yun Tian, M.D, Peking University Third Hospital, Beijing, China
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 24, 2019
Primary Completion (Actual)
November 30, 2019
Study Completion (Actual)
December 30, 2019
Study Registration Dates
First Submitted
July 13, 2019
First Submitted That Met QC Criteria
July 31, 2019
First Posted (Actual)
August 2, 2019
Study Record Updates
Last Update Posted (Actual)
June 18, 2021
Last Update Submitted That Met QC Criteria
June 17, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Musculoskeletal Diseases
- Neuromuscular Diseases
- Peripheral Nervous System Diseases
- Pathological Conditions, Anatomical
- Spinal Diseases
- Bone Diseases
- Body Temperature Changes
- Hernia
- Intervertebral Disc Displacement
- Radiculopathy
- Fever
- Spinal Stenosis
- Physiological Effects of Drugs
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Antipyretics
- Acetaminophen
Other Study ID Numbers
- IRB00006761-M2019299
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Disc Herniation
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingLumbar Disc Herniation | Lumbar Disc DegenerationChina
-
Shin Kong Wu Ho-Su Memorial HospitalTerminatedLumbar Disc Herniation | Lumbar Traction | Spinal Manipulation | Lumbar SurgeryTaiwan
-
Intrinsic TherapeuticsActive, not recruitingLumbar Disc Herniation | Annular Disc Tear | Annular Tear of Lumbar DiscBelgium, Germany
-
Allina Health SystemTwin Cities Spine CenterRecruitingLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Disc DiseaseUnited States
-
Holger JoswigCompletedLumbar Disc Herniation | Cervical Disc HerniationSwitzerland
-
Jaseng Medical FoundationRecruitingLumbar Disc HerniationKorea, Republic of
-
Firat UniversityRecruiting
-
Eastern Mediterranean UniversityRecruiting
-
Ramathibodi HospitalNot yet recruitingLumbar Disc Herniation
-
Zhou XingchenActive, not recruitingLumbar Disc HerniationChina
Clinical Trials on Tylenol
-
PfizerRecruitingInvasive Fungal DiseaseChina
-
Defense and Veterans Center for Integrative Pain...CompletedLaparoscopic CholecystectomyUnited States
-
Children's Mercy Hospital Kansas CityCompletedPerforated AppendicitisUnited States
-
Nova Scotia Health AuthorityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.CompletedInguinal Hernia | Abdominal Hernia | Laparoscopic Cholecystectomy | Umbilical HerniaCanada
-
Ohio State UniversityNational Center for Research Resources (NCRR); National Center for Advancing...Completed
-
Janssen Korea, Ltd., KoreaCompleted
-
Wake Forest University Health SciencesTerminated
-
Vanderbilt University Medical CenterCompletedCardiopulmonary Bypass | Congenital Heart DiseaseUnited States
-
Vanderbilt UniversityCompletedCardiopulmonary Bypass Induced Lipid PeroxidationUnited States
-
Tufts UniversityNational Institute of General Medical Sciences (NIGMS)CompletedPain | Fever | HepatotoxicityUnited States